Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 18, 2017

View Archived Issues

Positive phase I/IIa data for jCell in retinitis pigmentosa

Izana Bioscience launches, obtains rights to Takeda's namilumab for ankylosing spondylitis

Myonexus Therapeutics secures financing to develop gene therapies for limb-girdle muscular dystrophy

Kyn Therapeutics completes series A financing

Vaccine to protect against H. influenzae type A licensed to InventVacc for manufacturing

New models of epileptic encephalopathy type 26 employ novel mutation

CHMP grants positive opinion to Cx601 for the treatment of perianal fistulas in Crohn's disease

Lysyl oxidase inhibitor from Pharmaxis shows promise in model of primary myelofibrosis

BioTheryX describes novel cereblon-binding small molecules

Jnana Therapeutics launches with series A financing to target metabolic genes

FDA lifts clinical hold on Alnylam Pharmaceuticals' fitusiran

Long non-coding RNA linked to lymph node metastasis in breast cancer

Pfizer launches Ibrance in Japan

EMA committee hands down positive opinion on burosumab for X-linked hypophosphatemia

Celgene and Cancer Research Technology enter drug discovery collaboration

Celltrion's trastuzumab biosimilar recommended for E.U. approval

EMA committee recommends approval of Ozempic for type 2 diabetes

Athenex begins IND process for oral eribulin

Phase Ib study of TG-02 in RAS-mutated colorectal cancer passes initial safety review

FDA grants priority review to Tagrisso sNDA in NSCLC

Horizon Discovery in agreement with Roche Diagnostics to support development of IHC assays

EMA committee recommends approval of Alkindi for pediatric adrenal insufficiency

Bristol-Myers Squibb initiates phase III study of BMS-986205 with nivolumab in advanced melanoma

Novel IRAK inhibitors discovered at Pharmacyclics

Chiesi patents neutrophil elastase inhibitors

DuoGel studied in phase I pharmacokinetic trial

AbbVie Sarl, Galapagos identify novel CFTR modulators

Ferring presents new angiotensin AT1 receptor antagonists

Bristol-Myers Squibb divulges novel Rho kinase 2 inhibitors

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...